Acute Myeloid Leukemia (AML)

Jenna Moran, MSN, FNP-BC

Institution
Massachusetts General Hospital Cancer Center
Physician Status
available for consultation
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
About
Jenna Moran, MSN, FNP-BC, is an oncology nurse practitioner with the Leukemia department at the Massachusetts General Hospital Cancer Center in Boston, MA. She has experience in both the ambulatory and inpatient care settings. Her current areas of clinical focus include acute myeloid leukemia, acute lymphocytic leukemia, chronic myeloid leukemia and myelodysplastic syndrome. She has worked as clinical faculty at Simmons College as an instructor for medical surgical nursing. Additionally, she has worked as a global health nurse educator providing bone marrow transplant education and training to

Aura Ramos, RN, BSN

Institution
Massachusetts General Hospital Cancer Center
Physician Status
available for consultation
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
About
Aura Ramos, RN, BSN, is a leukemia research nurse at the Massachusetts General Hospital Cancer Center in Boston for the past 6 years. Aura has over 16 years of nursing experience caring for oncology patients in the ambulatory and inpatient setting. Prior to becoming a research nurse, she worked as a staff nurse on the leukemia and bone marrow transplant unit. She had the opportunity to travel to Dhaka, Bangladesh and educate nurses on caring for bone marrow transplant and leukemia patients. As a research nurse, she continues to educate staff on the administration of new research oral and

SY-1425

SY-1425: SY-1425 is a selective retinoic acid receptor alpha (RARα) agonist for genomically defined subsets of patients whose disease is characterized by the overexpression of the RARA gene.

Scientists discover two unique subtypes of a prominent mutation in patients with AML

Original Publication Date
Article Source
External Web Content
Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present in many patients with Acute Myeloid Leukemia (AML) – called NPM1 – that could help predict survival and improve treatment response for patients whose leukemic cells bear…

Joshua Zeidner, MD

Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Zeidner's research interests include discovering innovative methods to improve outcomes, drug discovery and development, and designing clinical trials in acute myeloid leukemia (AML) myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). He leads the Leukemia Clinical Trials Research Protocol Office Disease (POD) Group where we have a multitude of cutting-edge clinical trials for acute leukemia, MDS, and MPNs. Dr. Zeidner's the Principal Investigator of industry-sponsored, investigator-initiated, and academic collaborative clinical trials evaluating novel agents in MDS

Katherine Tarlock, MD

Institution
Seattle Children's Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Pediatric
About
Katherine Tarlock, M.D., is a board certified physician at Seattle Children’s Hospital and a UW assistant professor of pediatrics. Dr. Tarlock believes the privilege of caring for patients and families during challenging medical diagnoses is what drew her to this field and continues to be the best part of her job. She is dedicated to advancing our understanding of leukemia and being able to offer every child and family the best care. Dr. Tarlock earned her M.D. at Chicago Medical School. She is board certified in both Pediatrics and Pediatric Hematology/Oncology.

Stephan Paul, MD, JD

Institution
J. W. Ruby Memorial Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelomonocytic Leukaemia (CMML)
Myelodysplastic Syndromes (MDS)
Pediatric

Jane Liesveld, MD

Institution
Strong Memorial Hospital
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.